Silver Book Fact

Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.

Campbell C, Kipnes M, Stouch B, et al. Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy. Pain. 2012; 153(9): 1815-23. http://www.ncbi.nlm.nih.gov/pubmed/22683276

Reference

Title
Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy
Publication
Pain
Publication Date
2012
Authors
Campbell C, Kipnes M, Stouch B, et al
Volume & Issue
Volume 153, Issue 9
Pages
1815-23
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Researchers have developed several sub-types of ion channels that allow inflammation and growth factors to trigger persistent pain.  
  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.